April 30, 2009 (FinancialWire) — China Pharma Holdings, Inc. (OTCBB: CPHI) has appointed Frank Waung as the company’s chief financial officer. He most recently served as a managing director at boutique investment-banking firm Hickey Friehofner Capital.

Prior to Hickey Friehofner, Frank was a special situation analyst at DellaCamera Capital Management. He also served as a senior economist and a convertible bond analyst at SG Cowen.

Xihua Wu, who served as the CFO to China Pharma’s Helpson unit since 1999, and as CFO and a director to CPHI since 2005, has resigned for personal reasons.

Haikou City, China-based China Pharma Holdings is a specialty pharmaceutical company that develops, manufactures, and markets treatments in China for a range of conditions including cardiovascular, CNS, infectious, and digestive diseases.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.